Aqtual Presents Data Linking Blood-Based Biomarkers to Tissue Biology and Treatment Response in Rheumatoid Arthritis

Posted on by sHq_LoGiNz

HAYWARD, Calif. & ORLANDO, Fla.–(BUSINESS WIRE)–New Aqtual studies reveal why rheumatoid arthritis patients respond to different therapies, supporting development of its RA treatment-selection test.

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance (opens in a new tab)
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.